The sheer scale of the urban diabetes challenge means that no single organisation can solve it alone.
The programme is built on a public‑private partnership that drives cross‑disciplinary and cross‑sector collaboration.
Working together, we aim to build cities that help us live healthier lives, and where people with diabetes can live life to the full.
Over the last few years, University College London has put its weight behind understanding the impacts of urbanisation. Under its ‘Grand Challenge’ commitments to global health, sustainable cities, intercultural interaction and human well‑being, a cross‑disciplinary group contributes to urban sustainability by identifying health vulnerabilities and addressing the impact of NCDs globally. The expertise of applied researchers at the University College London, together with global partners, will underpin Cities Changing Diabetes. They aim to ensure sustainable impact, bringing new momentum to this global initiative.
Steno Diabetes Center is a world leading, not‑for‑profit institution specialising in diabetes care and prevention. Established by Novo Nordisk A/S in 1932, the organisation works in partnership with the Danish healthcare system. As a global partner in Cities Changing Diabetes, Steno Diabetes Center Copenhagen draws on its experience creating innovative and sustainable approaches to tackling diabetes at community level, training healthcare professionals around the world and in providing care in Copenhagen. The centre expects to make a significant contribution to the fight against urban diabetes.
Novo Nordisk is at the forefront of discovery, development and manufacturing of next‑generation medicines for the treatment of diabetes and is committed to making them accessible wherever they are needed. But living with chronic disease requires more than medicine, which is why Novo Nordisk helps people achieve the right outcomes through improved disease management. Novo Nordisk is committed to fighting diabetes on all fronts, and Cities Changing Diabetes is at the heart of this commitment.
Created and led by cities, C40 is focused on tackling climate change and driving urban action that reduces greenhouse gas emissions and climate risks, while increasing the health, wellbeing and economic opportunities of urban citizens. In late 2015, Novo Nordisk and C40 formed a research‑based partnership aimed at ensuring that urban climate action is beneficial to both the environment and the health of urban citizens. This collaboration aims to generate new insights into a range of benefits of climate action – in particular the health of city populations. At the heart of the partnership lies the pivotal role of cities in the fight against climate change and poor health.
EAT is a non‑profit organisation founded by the Stordalen Foundation, Stockholm Resilience Centre and the Wellcome Trust to catalyze a food system transformation. EAT is the science‑based global platform for food system transformation with a vision of a fair and sustainable global food system for healthy people and planet – leaving no one behind. EAT’s mission is to transform the global food system through sound science, impatient disruption and novel partnerships.EAT partners with a range of foundations, academic institutions, organizations and companies to collaborate on programs and to provide strategic advice, knowledge and financial support. In June 2018, Novo Nordisk and EAT entered a strategic partnership to work towards a healthier future for all people and the plane